Literature DB >> 15885677

Immunostimulatory activity of major membrane protein-II from Mycobacterium leprae.

Masahiko Makino1, Yumi Maeda, Norihisa Ishii.   

Abstract

We examined the antigenicity of an immunomodulatory protein, major membrane protein (MMP)-II, from Mycobacterium leprae, since host defense against M. leprae largely depends on adaptive immunity. Both unprimed and memory T cells from healthy individuals were stimulated by autologous MMP-II-pulsed monocyte-derived dendritic cells (DCs) to produce IFN-gamma. The DC-mediated IFN-gamma production was dependent on the expression of MHC, CD86, and MMP-II antigens. Memory T cells from paucibacillary (PB) leprosy more extensively responded to MMP-II-pulsed DCs than T cells from healthy individuals, while comparable IFN-gamma was produced by unprimed T cells. Memory T cells from multibacillary leprosy, which are normally believed to be anergic, were activated similarly to those from healthy individuals by MMP-II-pulsed DCs. These results suggest that memory T cells from PB leprosy are primed with MMP-II prior to the manifestation of the disease, and MMP-II is highly antigenic in terms of activation of adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885677     DOI: 10.1016/j.cellimm.2005.04.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Authors:  Karina I Carvalho; Fernanda R Bruno; Jennifer E Snyder-Cappione; Solange M Maeda; Jane Tomimori; Marilia B Xavier; Patrick A Haslett; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

2.  Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae.

Authors:  Masahiko Makino; Yumi Maeda; Katsuya Inagaki
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

3.  Gene expression profile and immunological evaluation of unique hypothetical unknown proteins of Mycobacterium leprae by using quantitative real-time PCR.

Authors:  Hee Jin Kim; Kalyani Prithiviraj; Nathan Groathouse; Patrick J Brennan; John S Spencer
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

Review 4.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Efficient activation of human T cells of both CD4 and CD8 subsets by urease-deficient recombinant Mycobacterium bovis BCG that produced a heat shock protein 70-M. tuberculosis-derived major membrane protein II fusion protein.

Authors:  Tetsu Mukai; Yumiko Tsukamoto; Yumi Maeda; Toshiki Tamura; Masahiko Makino
Journal:  Clin Vaccine Immunol       Date:  2013-10-23

6.  Immunostimulatory activity of major membrane protein II from Mycobacterium tuberculosis.

Authors:  Yumiko Tsukamoto; Masumi Endoh; Tetsu Mukai; Yumi Maeda; Toshiki Tamura; Masanori Kai; Masahiko Makino
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

Review 7.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27

8.  Polyclonal activation of naïve T cells by urease deficient-recombinant BCG that produced protein complex composed of heat shock protein 70, CysO and major membrane protein-II.

Authors:  Yumiko Tsukamoto; Yumi Maeda; Toshiki Tamura; Tetsu Mukai; Masahiko Makino
Journal:  BMC Infect Dis       Date:  2014-04-02       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.